Family Medicine, ENT, and Sleep Medicine is organized by Continuing Education, Inc. and will be held from Aug 17 - 27, 2020 at Celebrity Constellation, Venice, Veneto, Italy. Target Audience: Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists Credits: • 14 AMA PRA Category 1 Credits™ • 14 ACPE Credits  • 14.0 Contact Hours  Program Purpose: The purpose of this CME activity is to review and discuss common general medical conditions and to provide guidelines for their management and to provide updated guidelines for prevention of common primary care conditions. Topics have been chosen to benefit the family physician, general internist and Advance Practice Professionals in an ambulatory care setting. Topics: • Healthy Lifestyles and the Obesity Epidemic ○ Discuss the epidemiology of obesity ○ Discuss the role of lifestyle habits in prevention and management of obesity • Screening for Cardiovascular Disease and Cancer ○ Distinguish the difference between primary, secondary, and tertiary prevention. ○ Enumerate the recommended screening tests for breast, colon and lung cancer and their timing. ○ Describe the recommended guidelines for blood pressure screening, cholesterol screening, and diabetes screening. • Evidence-based Exercise and Diet options for Cardiovascular Prevention ○ Describe the recommended levels of exercise for adults. ○ Describe the most appropriate diet for patients with diabetes or hypertension. • The Physiologic Basis of a Healthy Diet and Exercise - a primer ○ Provide at least three physiologic effects of exercise on human cells ○ Describe three physiologic mechanisms for the impact of fruits and vegetables on health • Update on Pneumonia Management ○ Describe the most common causes of community-acquired pneumonia. ○ Identify the latest recommended initial empiric treatment of patients with community-acquired pneumonia with or without co-existing morbidities. • Update on COPD Management ○ Describe the classification of severity of COPD according to symptoms and spirometry values. ○ Identify the recommended initial treatment of patients with COPD according to severity. • Update on Asthma Management ○ Describe the classification of asthma according to symptoms and spirometry values. ○ Identify the recommended initial treatment of patients with asthma for each level of severity ○ Describe the important differences between treatment options for asthma and treatment for COPD.

This conference has been POSTPONED. The revised dates will be updated soon after they are confirmed. 11-Night Italy, Malta & Best Of Greece Cme Cruise is organized by Sea Courses Inc and will be held from Aug 17 - 28, 2020 at Celebrity Edge, Rome, Lazio, Italy. The target audience for this medical event is family physicians, specialists, and allied health care professionals. Course Description : The aim is to provide evidence-based material, as well as practical and relevant clinical pearls that will be easy to implement into one’s own medical practice. Conference attendees will be invited to complete a pre-course Needs Assessment to assist the faculty with the development of their presentations. Additional details will be posted as soon as they are available. 

10th World Congress of the World Institute of Pain (WIP) 2020 is organized by World Institute of Pain (WIP) and will be held from Aug 26 - 29, 2020 at Rome Marriott Park Hotel, Rome, Lazio, Italy. This Conference is also held as Virtual. Additional details will be posted as soon as information is available.

PLEASE NOTE: THIS IS NOT A CURRENTLY ACTIVE PROGRAM.   Delivering Personalized Medicine: Focus on Pharmacogenomics, Medication Optimization and Collaborative Care Models to Enhance Patient Outcomes & Topics in Allergy and Immunology is organized by Continuing Education, Inc. and will be held from Sep 05 - 12, 2020 at Royal Caribbean's Rhapsody of the Seas, Venice, Veneto, Italy. Target Audience: Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists Accreditation: • 14 AMA PRA Category 1 Credits™ • 14 ACPE Credits • 14.0 Contact Hours • 8 Hours of Pharmacology for NPs Program Purpose: This program will focus on the following and allow participants to: • Recognize the evolving role pharmacogenomics is playing in the delivery of personalized medicine. • Describe common sources for medication-related miscommunications and how poor medication adherence can impact the clinical and economic outcomes for patient, providers, and stakeholders. • Discuss the rationale for collaborative models of care that deliver enhanced clinical, patient, and economic outcomes. From Pharmacogenomics to Personalized Medicine: After attending the following session individuals should be able to: • Identify new personal health care technologies and the impact they may have on patient outcomes. • Distinguish benefits and limitations of genetic testing and use in managing medications in specific patients. • Evaluate various gene-drug (biomarker-drug) pairs with pharmacogenomic applications. • Critique the various resources (e.g., CPIC, PharmGKB, FDA) for pharmacogenomics drug-gene pairs. • Understand the difference between preemptive and reactive testing of drug-gene pairs. • Discuss the economic cost or impact considerations related to pharmacogenomic testing. • Understand practical approaches to counseling/patient education related to pharmacogenomics. Optimizing Medication Adherence and Outcomes: After attending the following session individuals should be able to: • Create strategies to promote medications adherence among all healthcare providers. • Describe the impact of poor adherence on clinical and economic outcomes for patient and stakeholders. • Associate the necessary points within the medication use system in which technologies can be employed to reduce medical errors and enhance patient outcomes Comprehensive Medication Management Services: After attending the following session individuals should be able to: • Outline the value of leveraging the prescription benefit to reduce downstream healthcare costs and outcomes. • Critique the rationale for collaborative models of care that deliver enhanced clinical, patient and economic outcomes that involves pharmaceutical benefits. • Recognize the importance of aligning incentives in a “pay for performance” model that includes all providers. Topics in Allergy and Immunology: • Urticaria • Angioedema • Atopic Dermatitis • Food Allergy • Drug Allergy • Sinusitis • Indoor Allergies

UCSF Imaging Update in Tuscany is organized by The University of California, San Francisco (UCSF) Office of Continuing Medical Education and will be held from Sep 07 - 11, 2020 at Grand Hotel Baglioni, Florence, Tuscany, Italy. Additional details will be posted as soon as they are available.

Internal Medicine for Primary Care: Addiction/Gastro/Pulm/Rheum is organized by Medical Education Resources (MER) and will be held from Sep 07 - 10, 2020 at Hilton Sorrento Palace, Sorrento, Campania, Italy. Target Audience: This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine Accreditation: Physician Accreditation: Medical Education Resources designates this live activity for a maximum of 16 AMA PRA Category 1 Credit(s)™. ABIM MOC Recognition: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16 (part II) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. American Academy of Family Physicians: This Live activity, Internal Medicine for Primary Care, with a beginning date of September 7, 2020 has been reviewed and is acceptable for up to 16 Prescribed credits by the American Academy of Family Physicians. American Osteopathic Association: These programs are approved for 16 hours in Category 2-A by the American Osteopathic Association. American College of Emergency Physicians: This program is approved by the American College of Emergency Physicians for a maximum of 16 hours of ACEP Category I credit. American Academy of Physician Assistants: Physician assistants may receive a maximum of 16 hours of Category I credit for completing this program. Nursing Accreditation: This CE activity provides 16 contact hours of continuing nursing education. Pharmacy Accreditation: MER designates this continuing education activity for 16 contact hours (1.6 CEUs) of the Accreditation Council for Pharmacy Education.  Topics May Include: Internal Medicine for Primary Care: • Addiction Medicine • Allergy & Immunology • Bariatrics • Cardiology • Dermatology • Ear, Nose & Throat • Endocrinology • Emergency Medicine • Gastroenterology • Geriatrics • Gynecology • Infectious Diseases • Medicolegal • Men’s Urology • Neck & Spine • Nephrology • Neurology • Obstetrics • Oncology • Ophthalmology • Orthopedics • Pain • Palliative Care • Podiatry • Psychiatry • Pulmonology • Radiology • Rheumatology • Sports Medicine • Toxicology • Vascular Medicine Learning Objectives: Upon completion of this program, participants should be better able to: • Identify at risk patients, institute diagnostic criteria, and manage fatty liver • List current treatment recommendations for celiac disease and lower GI bleeding • Discuss current recommendations for screening and surveillance of colorectal cancer • Describe strategies for identifying and treating substance use disorders • Discuss options for patients with chronic pain addictions • Identify the pathophysiology and diagnostic approach of asthma, COPD and common respiratory infections • Design treatment strategies reflective of current evidence based medicine for asthma, COPD and common respiratory infections • Discuss systemic consequences and counseling strategies, as well as available treatment options for sleep apnea • Evaluate and treat fibromyalgia • Utilize current evidence to design treatment strategies for inflammatory arthritis and osteoarthritis Learning Outcome: To provide updates in primary care medicine to office based providers

Computing in Cardiology (CinC) Conference is organized by Computing in Cardiology (CinC) and will be held from Sep 13 - 16, 2020 at Rimini, Emilia-Romagna, Italy. Additional details will be posted as soon as they are available.

Prato Masterclass in Gynaecology is organized by Monash University and will be held from Sep 14 - 15, 2020 at Monash University, Prato Centre, Prato, Tuscany, Italy. Who should participate? Obstetric and Gynaecology Specialists, and Specialist-in-training. Description: A two-day intensive Masterclass in Gynaecology led by expert clinicians. Limited places will ensure many opportunities for one-on-one conversations between speakers and participants. Let’s talk about evidence-based care! Join us and get ready for a great educational meeting and to appreciate an amazing food experience and the gorgeous region of Florence, Italy! Session Titles: • Endometriosis • Defining the Research Agenda for Endometriosis • The ovary • Polycystic ovary syndrome • Abnormal uterine bleeding • Birth Trauma • Pelvic floor disorders • Ectopic pregnancy Expert speakers: Australian Faculty: • Professor Beverley Vollenhoven – Monash University, Australia • Assoc Prof Jim Tsaltas – Monash University, Australia • Professor Ben Mol – Monash University, Australia • Professor Luk Rombauts – Monash University, Australia • Assoc Prof Anna Rosamilia – Monash University, Australia • Dr Stuart Salfinger – President, Australasian Gynaecological Endoscopy & Surgery Society (AGES) International Faculty: • Professor Dirk Timmerman – Katholieke Universiteit Leuven, Belgium • Professor Marlies Bongers – Maastricht University, Netherlands • Professor Hervé Fernandez – Hôpital Bicêtre, France • Professor Andrew Horne – The University of Edinburgh, UK • Professor Paolo Vercellini – Università degli Studi di Milano, Italy • Professor Mario Malzoni – Center for Advanced Endoscopic Gynecologic Surgery, Italy • Prof Stefano Salvatore - San Raffaele Hospital Milan, Italy & Past-President, European Urogynaecological Association • Prof Robert Freeman – Plymouth Hospitals NHS Trust, UK •Dr Paivi Karjalainen – Central Finland Central Hospital, Finland • Dr Jackie Maybin – University of Edinburgh, UK

4th Impurities: Genotoxic and Beyond Summit is organized by Vonlanthen Group of Companies and will be held from Sep 15 - 16, 2020 at Eurostars Roma Aeterna, Rome, Lazio, Italy. Who Should Attend: Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in: • ADC (Antibody Drug Conjugates) • Analytical Science • API Development • Assay Development • Biotherapeutics • Carcinogenic Impurities • Carcinogenicity • Carcinogens • Chemistry (Analytical, Organic, • Medicinal, Protein) • Chromatography • Degradation Products • DNA Reactive Impurities • DNA Reactivity • Drug Design • Drug Development • Drug Discovery • Drug Safety • Drug Substance • Elemental Impurities • Extractables & Leachables • Formulation • Genetic Toxicology • Genotoxic Impurities • Genotoxicity • Genotoxin • GMP • Good Laboratory Practice • GRAs • GTIs • Impurities • In Silico • Large Molecule • LC-MS • Mass Spectrometry • Microscopy • Mutagenic Impurities • Mutagenicity • Nanomaterials • Nanoparticles • New Modality • Oligonucleotide • Organic Synthesis • Particles • Peptide • PGTIs • Preclinical Drug Safety • Process Chemistry • Process-Related Impurities • Product-Related Impurities • Protein • Purification • Purge Factors • Quality Assurance • Quality By Design (QbD) • Quality Control • Regulatory • R&D • Safety Assessment • Small Molecule • Spectroscopy • TDI • Technology Transfer • Threshold of Toxicological Concern (TTC) • Toxicology • Validation Course Description: This premier B2B summit will shed light on the compliant implementation practice of ICH M7 and Q3D and novel strategies for efficient mutagenic and elemental impurities identification and control.  It is an honor and privilege to invite you to participate in our Summit. Don’t miss out on this opportunity to discuss ideas with your peers while being part of a professional atmosphere and environment for good company representation and development.  Key Practical Learning Points: • Recent experience and perspectives on compliant implementation of ICH M7 and Q3D • Risk assessment of potentially genotoxic impurities and safety testing: critical issues and best practices for regulatory submissions • Extractables and leachables, elemental impurities in drugs and biologics: quality concerns, recommendations for comprehensive evaluations, upcoming changes in standards and regulations • Regulatory, toxicology, analytical practice for efficient mutagenic and elemental impurity identification, monitoring and control in pharmaceutical products, drug substances/APIs and excipients • Considerations for genotoxicity assessment of peptide/protein-related and novel oligonucleotide-based biotherapeutics • Valsartan incident and its implications for ICH M7

Expo Dental Meeting 2020 is organized by Promunidi Srl and will be held from Sep 17 - 19, 2020 at Rimini Fiera (RN), Rimini, Emilia-Romagna, Italy. Additional details will be posted as soon as information is available.